NCT07290504 Gradual Versus Intermittent Release of Tourniquet Effect on MAP in Hypertensive Patients Undergoing Upper Limb Orthopedic Surgeries
| NCT ID | NCT07290504 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kasr El Aini Hospital |
| Condition | Hemodynamics |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2025-12-13 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2025-12-13 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this clinical trial, the authors will compare two tourniquet deflation techniques and their clinical implications on hemodynamics and acid base parameters in hypertensive orthopedic patients undergoing upper limb surgeries under general anesthesia.
Eligibility Criteria
Inclusion Criteria: * Hypertensive patients (controlled on medical treatment more than three months) * Patients scheduled for upper limb orthopedic surgeries using a tourniquet for at least 30 min. * BMI from 18.5 to 29.9 Exclusion Criteria: * Patient refusal * ASA physical status \> II * Multiple orthopedic surgeries * Emergency surgeries * Patient with relative contraindications for tourniquet use
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07290504 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Hemodynamics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07290504 currently recruiting?
Yes, NCT07290504 is actively recruiting participants. Contact the research team at khaled.sarhan@kasralainy.edu.eg for enrollment information.
Where is the NCT07290504 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07290504 clinical trial?
NCT07290504 is sponsored by Kasr El Aini Hospital. The trial plans to enroll 68 participants.